Candriam SCA’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-165,000
| Closed | -$4.45M | – | 720 |
|
|
2024
Q1 | $4.45M | Buy |
165,000
+55,000
| +50% | +$1.48M | 0.03% | 360 |
|
|
2023
Q4 | $3.3M | Buy |
110,000
+60,000
| +120% | +$1.8M | 0.02% | 399 |
|
|
2023
Q3 | $1.02M | Hold |
50,000
| – | – | 0.01% | 551 |
|
|
2023
Q2 | $994K | Hold |
50,000
| – | – | 0.01% | 603 |
|
|
2023
Q1 | $788K | Hold |
50,000
| – | – | 0.01% | 721 |
|
|
2022
Q4 | $978K | Buy |
+50,000
| New | +$978K | 0.01% | 700 |
|
|
2021
Q2 | – | Sell |
-128,749
| Closed | -$6.78M | – | 929 |
|
|
2021
Q1 | $6.78M | Hold |
128,749
| – | – | 0.06% | 321 |
|
|
2020
Q4 | $7.06M | Buy |
+128,749
| New | +$7.06M | 0.06% | 329 |
|